Hospira Receives FDA Clearance for Plum 360™ Infusion System

0

Hospira report “Hospira, Inc. (NYSE: HSP), the world’s leading provider of injectable drugs and infusion technologies, today announced that the company has received 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Plum 360™ infusion system with Hospira MedNet™ safety software.

The newest in Hospira’s portfolio of infusion devices, the Plum 360 system builds on the unique air management and secondary delivery features of Plum A+™, while expanding its drug library and wireless capability to enable streamlined electronic medical record (EMR) integration.”

Full Story

Thank you to our partners for supporting IVTEAM

Share.

Comments are closed.

Free Email Updates
Join 5.5K IVTEAM members. Subscribe now and be the first to receive all the latest free updates from IVTEAM!
100% Privacy. We don't spam.